Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features.
about
A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors.Clinical and epidemiologic profile of breast cancer in Tanzania.Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in EgyptInflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and MoroccoConsiderations in setting up and conducting epidemiologic studies of cancer in middle- and low-income countries: the experience of a case-control study of inflammatory breast cancer in North Africa in the past 10 years.Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008).Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and TunisiaCorrelation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma.What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathwaysBisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells.Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.Breast cancer by age at diagnosis in the Gharbiah, Egypt, population-based registry compared to the United States Surveillance, Epidemiology, and End Results Program, 2004-2008.Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients.
P2860
Q30724470-C9625799-80C1-4937-922E-54A9527E3DC6Q34640608-698A466C-82DE-4A94-83E9-50DD8CC47089Q34769643-367FAF66-070F-4066-8E88-1A0E234F18FAQ34917731-9A502BFA-CE37-4112-B545-559F798A0C54Q34918207-428182CB-5545-4B6D-B52C-E6031A48C036Q36530766-00B4FB92-F50F-433E-8634-4C6DB3792B29Q36598732-1E945971-5E86-47A7-8D42-550E67E9F228Q36804861-01398F31-1FAA-4651-874B-CD442528574AQ36960615-2E02CC74-1E5F-4CC2-8AEC-05E26F9C3793Q37210821-7FC65191-B152-4C89-A167-AE25E3D0732EQ37686006-B9D930C8-47BD-43B6-A025-52ADC1D37CB4Q38706762-BC8013C4-33A8-4AA2-B346-DF02A205D4EBQ39214862-49E361C0-C819-4A96-9FC1-2D1ECBC30270Q39436785-A07952F6-F374-4313-BA4F-0F1B4E1162D1Q46511043-96484D75-CF8B-47FD-AB08-0ACA78BF9BF4
P2860
Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Inflammatory breast cancer in ...... clinicopathological features.
@en
type
label
Inflammatory breast cancer in ...... clinicopathological features.
@en
prefLabel
Inflammatory breast cancer in ...... clinicopathological features.
@en
P2093
P1433
P1476
Inflammatory breast cancer in ...... clinicopathological features.
@en
P2093
Amor Gamoudi
Hamouda Boussen
Hatem Bouzaiene
Jamel Ben Hassouna
Khaled Rahal
P356
10.1053/J.SEMINONCOL.2007.11.017
P50
P577
2008-02-01T00:00:00Z